You are here: » People » Researcher » Scanlon, Peter

Peter Scanlon


CV of Peter Scanlon [pdf]

Scientifc Interest

  • Diabetic retinopathy screening
  • Treatment of Diabetic Retinopathy
  • Quality of Life for patients with diabetic retinopathy
  • Imaging of the Eye


  • Member of the Royal College of Ophthalmologists
  • Fellow of the Royal College of Physicians
  • UK Diabetes Research Network (DRN) Clinical Studies Advisory Group
  • European Vision Institute, Clinical Trials, Site of Excellence (EVI.CT.SE)
  • Diabetic Retinopathy Subcommittee of the European EVI.CT.SE Retina Specialists
  • Gloucestershire Countywide R & D Consortium

Further Activities

  • Programme Director for the Diabetic Retinopathy Programme in England (since 1st August 2002, prior to introduction in 2003).
  • Consultant Ophthalmologist, Gloucestershire Eye Unit, Cheltenham General Hospital (since 2nd October 2006)
  • Director of the Gloucestershire Diabetic Eye Screening Service (since 1st October 1998)
  • Consultant Ophthalmologist, Oxford Eye Hospital, substantive since 1st August 2007
  • Senior Research Fellow and Tutor in Medicine, Harris Manchester College, University of Oxford
  • Tutor to the Speciality Doctor Group (SAS) at Gloucestershire Hospitals NHS Financial Trust
  • Honorary Associate Professor, University of Warwick Medical School
  • Organiser of a successful 4 Nations DR Research Group, leading to a DRN Writing Group
  • Organiser of a successful European Conference in May 2009 in Oxford – the European Association for the Study of Diabetic Eye Complications (EASDec)
Peter Scanlon
Peter Scanlon

Research Group

Gloucestershire Diabetic Retinopathy Research Group

[more information]


Gloucestershire Hospitals NHS Foundation Trust

Cheltenham General Hospital

Sandford Road
GL53 7AN
Cheltenham, Gloucestershire
United Kingdom

Phone: (44) 08454 222 851
Fax: (44) 08454 223 853


Key Publications

  1. Sallam A, Scanlon PH, Stratton IM, Jones V, Martin CN, Brelen M and Johnston RL
    Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy.
    Diabetic Medicine 2011. E-pub ahead of print.
  2. Scanlon PH
    Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy.
    Eye (Lond) 2010. 24(3): 435-440
  3. Taylor DJ, Goatman KA, Gregory A, Histed MG, Martin CN, Warburton TJ and Scanlon PH
    Image quality standardisation for diabetic retinopathy screening.
    Expert Review of Ophthalmology 2009. 4(5):469-476
  4. Scanlon PH, Carter S, Foy C, Husband R, Abbas J and Bachmann MO
    Diabetic retinopathy and socio-economic deprivation in Gloucestershire.
    J Med Screen 2008. 15(3):118-21
  5. Scanlon PH, Foy C and Chen FK
    Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
    Br J Ophthalmol 2008. 92(6):775-8
  6. Scanlon PH
    The English national screening programme for sight-threatening retinopathy.
    J Med Screen 2008. 15(1):1-4
  7. Scanlon PH, Martin ML, Bailey C, Johnston E, Hykin P and Keightley S
    Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy.
    Diabetic Medicine 2006. 23(1): 60-6.
  8. Scanlon PH, Foy C, Malhotra R and Aldington SJ
    The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening.
    Diabetes Care 2005. 28(10):2448-53.
  9. Scanlon PH, Carter S, Foy C, Ratiram D and Harney B
    An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.
    Br J Ophthalmol 2005 89(8):971-5.
  10. Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N, Harney B, Aldington SJ
    The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy.
    Diabetic Medicine 2003. 20 (6), 467-474.

Research Groups